Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic ...

Exciting research unveils a single-dose treatment that could potentially change breast cancer therapy by eliminating small tumors and reducing large ones in mice without notable side effects. A ...

“It is very rare for a compound to shrink tumors in mouse models of breast cancer, let alone completely eradicate those tumors with a single dose, so we are eager for ErSO-TFPy to advance for ...